Over the past week, regulatory updates spanned approvals, safety statements and policy shifts. The FDA authorized imlunestrant for ESR1-mutated advanced breast cancer, while Australia’s TGA reversed ...
19hon MSN
What is lecanemab, the newly approved Alzheimer’s drug? Can it really slow down dementia?
The drug may slow the progression of Alzheimer’s disease, but it doesn’t improve the symptoms. It’s also incredibly expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback